NCT00193362View on ClinicalTrials.gov

Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

September 30, 2007

Conditions

Lung Cancer

Interventions

DRUG

Paclitaxel

DRUG

Carboplatin

DRUG

Gemcitabine

DRUG

Vinorelbine

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER